EZETIMIBE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 16 adverse event reports in the FDA FAERS database where EZETIMIBE was used for Psoriasis.
Most Reported Side Effects for EZETIMIBE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Myalgia | 2,066 | 15.8% | 194 | 178 |
| Fatigue | 876 | 6.7% | 183 | 101 |
| Drug ineffective | 812 | 6.2% | 9 | 197 |
| Arthralgia | 766 | 5.8% | 203 | 33 |
| Dyspnoea | 766 | 5.8% | 222 | 194 |
| Nausea | 742 | 5.7% | 174 | 149 |
| Dizziness | 717 | 5.5% | 204 | 117 |
| Diarrhoea | 688 | 5.3% | 207 | 106 |
| Headache | 626 | 4.8% | 199 | 39 |
| Malaise | 591 | 4.5% | 175 | 119 |
| Muscle spasms | 558 | 4.3% | 0 | 77 |
| Asthenia | 532 | 4.1% | 180 | 101 |
| Pruritus | 496 | 3.8% | 207 | 68 |
| Drug intolerance | 492 | 3.8% | 0 | 50 |
| Abdominal pain | 454 | 3.5% | 192 | 88 |
Other Indications for EZETIMIBE
Product used for unknown indication (4,125)
Hypercholesterolaemia (1,589)
Blood cholesterol increased (998)
Hyperlipidaemia (796)
Dyslipidaemia (787)
Type iia hyperlipidaemia (562)
Blood cholesterol (266)
Coronary artery disease (241)
Arteriosclerosis (216)
Ill-defined disorder (209)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)